SZWV and National Disability Insurance Agency [2022] AATA 2973 (12 September 2022)
Division:NATIONAL DISABILITY INSURANCE SCHEME DIVISION
File Number(s): 2021/7049
Re:SZWV
APPLICANT
AndNational Disability Insurance Agency
RESPONDENT
Decision
Tribunal:Member I Thompson
Date:12 September 2022
Place:Adelaide
The decision under review made by the Agency on 8 September 2021 is set aside pursuant to s 43(1) of the Administrative Appeals Tribunal Act 1975 (Cth) and in substitution the Tribunal decides:
Funding a Mollii Suit for the applicant, SZWV, in the sum of $10,500, is a reasonable and necessary support which is to be funded under the National Disability Insurance Scheme.
...............[Sgnd].......................................
Member I Thompson
Catchwords
NATIONAL DISABILITY INSURANCE SCHEME – review of statement of participant supports – reasonable and necessary supports – applicant sought review of statement of participant supports – request for funding for a Mollii Suit – decision set aside
Legislation
National Disability Insurance Scheme Act 2013 (Cth)
National Disability Insurance Scheme (Supports for Participants) Rules 2013 (Cth)
Cases
McGarrigle v National Disability Insurance Agency [2017] FCA 309
National Disability Insurance Agency v WRMF [2020] FCAFC 79
McCutcheon v National Disability Insurance Agency [2015] AATA 624
TKCW v National Disability Insurance Agency [2014] AATA 501
QTBR & National Disability Insurance Agency [2021] AATA 1951
McLaughlin & National Disability Insurance Agency [2021] AATA 496
REASONS FOR DECISION
Member I Thompson
12 September 2022
INTRODUCTION
The Applicant, SZWV, is a young participant in the National Disability Insurance Scheme (NDIS), which is administered by the Respondent, the National Disability Insurance Agency (the Agency). He resides with his parents and brother and sister. His mother advocated for him at the hearing. Aged 11, he has neurofibromatosis (NF1) and other issues which affect his health and wellbeing. NF1 is a genetic condition resulting in the formation of benign tumours affecting the nerves or skin. As a result of this condition, he has vision and speech impairments, reduced fine and gross motor skills, decreased muscle strength and reduced balance and coordination. He has undergone multiple surgeries to remove tumours.[1]
[1] Exhibit 11, p 436
As part of his therapy, SZWV was using a device called a Mollii Suit, which the Agency approved and funded for a trial period. The funding was discontinued following the trial and a request was made for an internal review of that decision. The request was not successful and SZWV stopped using the suit. In its explanation for declining the internal review request, the Agency review officer referred to criteria in the legislation and highlighted lack of available research and an evidence base for use of the Mollii Suit for people with NF1. Although SZWV’s occupational therapist had reported benefits, the review officer concluded that there was: “insufficient evidence of the formal outcome measures to show how the use of the suit will be more effective and beneficial in the short and long-term than currently funded capacity building supports.”[2]
[2] Exhibit 1, p 14
Funding of $ 10,500 is sought for the Mollii Suit.[3] In…
Keep reading for free
Create a free CaseChat account to read SZWV and National Disability Insurance Agency and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2022] AATA 2973
- Decision Date
CaseChat Overview and Summary
The Tribunal was required to consider whether the Mollii Suit met the criteria for reasonable and necessary supports as defined by the NDIS Act. Specifically, it needed to assess whether the support would be effective and beneficial for SZWV, having regard to current good practice, as stipulated by section 34(1)(d) of the Act. This involved evaluating the available evidence, including expert opinion, the lived experience of the participant and carers, and any relevant literature or consensus of expert opinion.
The Tribunal reasoned that while there was a paucity of refereed literature and no evidence of other children in like circumstances using the technology, the ordinary meaning of "effective" and "beneficial" needed to be applied. Evidence from SZWV's mother indicated significant improvements in his gross motor skills, posture, sleep, and a reduction in headaches during the period he used the Mollii Suit, with a noticeable decline upon cessation. The Tribunal also noted that SZWV himself expressed a desire to use the suit again because it made him "feel better." Considering this evidence alongside the goals outlined in SZWV's NDIS plan, the Tribunal concluded that the criteria for reasonable and necessary supports were satisfied.
Consequently, the Tribunal set aside the NDIA's decision of 8 September 2021. In substitution, the Tribunal ordered that funding for a Mollii Suit for SZWV, in the sum of $10,500, be provided as a reasonable and necessary support under the NDIS.
Orders
Orders of the court
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
In summary, the neurologist’s opinion is that the Mollii Suit is not likely to be beneficial for management of SZWV’s condition of NF1 and not likely to reduce the long-term need for physiotherapy and occupational therapy. That is an opinion which he expressed in his oral evidence and which he formed as a result of the literature search, his understanding of the Mollii Suit technology, which he has derived from the available literature, together with his own professional qualifications and experience.CONSIDERATION In McGarrigle v National Disability Insurance Agency, the term “support” is described by the Federal Court, per Mortimer J, as “a practical description of the means by which a person with disability is assisted”.[28][28] [2017] FCA 306 at [88] The Full Court of the Federal Court in National Disability Insurance Agency v WRMF discussed reasonable and necessary supports in s 34(1) of the NDIS Act:[29]... there is no doubt that the contextual use of the phrase [‘reasonable and necessary supports’] in this Act links it to public funding to be provided to a participant. In that context, the phrase connotes supports which meet a threshold which justifies — by reference to the context, objects and guiding principles of the Act and the facts of the case — the expenditure of public funds for that support, for a particular participant. As we have already explained, the phrase also needs to be understood taking into account what has qualified a person as a participant, and the links between a person’s impairment and their full participation in the community, in the same variety of ways as persons without a disability might choose to participate.[29] [2020] FCAFC 79 at [151] Under Support Rules 5.1(a), (b), (c) and (d), the Agency does not provide or fund a support under the NDIS if the circumstances set out in any one of those sub-rules apply.Whether the support will be, or is likely to be, effective and beneficial for the participant, having regard to current good practice s 34(1)(d) of the NDIS Act First, consideration will be given as to whether the requested support for funding of the Mollii Suit satisfies this requirement. Support Rules 3.2 and 3.3 require consideration of the available evidence of the effectiveness of the requested support for others in like circumstances. That evidence may include published and refereed literature and any consensus of expert opinion, it may include the lived experience of the participant or the carers and anything that the Agency has learnt through delivery of the NDIS. Expert opinion can be taken into account. In this case there is a paucity of refereed literature. SZWV’s neurological condition is rare. The technology in question is relatively new. There is no evidence of actual use of this technology by other children or young people in “like circumstances” to SZWV.Effective and beneficial The NDIS Act does not provide a definition of the words “effective” and “beneficial”. In McCutcheon v NDIA the Tribunal accepted that they are: “ordinary words that should be given their ordinary meaning. Relevant to these proceedings, “effective” in the Australian Oxford Dictionary means: having a definite or desired effect; efficient, and “beneficial” means advantageous; having benefits; improving the health.”[30][30] [2015] AATA 624 at [34]; NDIA Operational Guideline 10.6